 |
市場調査レポート
商品コード
1448312
遺伝子増幅技術の世界市場規模、シェア、成長分析：技術別、エンドユーザー別 - 産業予測（2024年～2031年）Global Gene Amplification Technologies Market Size, Share, Growth Analysis, By Technology(PCR, NASBA), By End user(Academic & research institutions, diagnostic labs) - Industry Forecast 2024-2031 |
||||||
| 遺伝子増幅技術の世界市場規模、シェア、成長分析：技術別、エンドユーザー別 - 産業予測（2024年～2031年） |
|
出版日: 2024年03月02日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の遺伝子増幅技術の市場規模は、2022年に39億6,000万米ドルとなり、2023年の43億6,000万米ドルから2031年には93億4,000万米ドルに拡大し、予測期間中（2024年～2031年）にCAGR10%で成長すると予測されています。
分子生物学と診断学の開拓により、遺伝子増幅技術の世界市場は力強い伸びを示しています。個別化医療、バイオテクノロジー研究、疾病診断への応用拡大が重要な動機となっています。この業界は等温増幅法とポリメラーゼ連鎖反応（PCR）増幅法が主流ですが、CRISPRベースの増幅法はますます普及しつつあります。北米は研究開発とヘルスケアのインフラがしっかりしているため、かなりの市場シェアを占めています。アジア太平洋は、ヘルスケアへの支出と技術利用の増加により急成長しています。ゲノミクスが医療・研究分野に影響を与え続けていることから、遺伝子増幅技術市場は安定した成長が見込まれています。
目次
エグゼクティブサマリー
- 市場概要
- 転変
調査手法
- 情報調達
- 二次・一次情報源
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
遺伝子増幅技術の世界市場：技術別
- 市場概要
- PCR
- NASBA
- LAMP
- その他
遺伝子増幅技術の世界市場：エンドユーザー別
- 市場概要
- 学術・研究機関
- 診断ラボ
- 製薬会社
遺伝子増幅技術の世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他欧州
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
- ラテンアメリカ
- ブラジル
- その他ラテンアメリカ
- 中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主要市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Thermo Fisher Scientific（USA）
- Roche Diagnostics（Switzerland）
- Agilent Technologies（USA）
- QIAGEN（Netherlands）
- Bio-Rad Laboratories（USA）
- Illumina（USA）
- Beckman Coulter（USA）
- Fluidigm Corporation（USA）
- Merck KGaA（Germany）
- BioMerieux（France）
- GenMark Diagnostics（USA）
- Cepheid（USA）
- Luminex Corporation（USA）
- Enzo Biochem（USA）
- Takara Bio（Japan）
- Sysmex Corporation（Japan）
- Promega Corporation（USA）
- Becton, Dickinson and Company（USA）
- DiaSorin S.p.A.（Italy）
- Eppendorf（Germany）
Global Gene Amplification Technologies Market size was valued at USD 3.96 billion in 2022 and is poised to grow from USD 4.36 billion in 2023 to USD 9.34 billion by 2031, growing at a CAGR of 10% during the forecast period (2024-2031).
The development of molecular biology and diagnostics has led to a strong increase in the global market for gene amplification technologies. Personalized medicine, biotechnology research, and growing applications in disease diagnostics are important motivators. The industry is dominated by isothermal and polymerase chain reaction (PCR) amplification methods, however CRISPR-based amplification is becoming more and more popular. Due to its robust R&D and healthcare infrastructure, North America has a sizable market share. Asia-Pacific is growing quickly as a result of increased healthcare spending and technology usage. With genomics continuing to influence the medical and research fields, the market for gene amplification technologies is expected to grow steadily.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Gene Amplification Technologies Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Gene Amplification Technologies Market Segmental Analysis
One may divide the worldwide market for gene amplification technologies into three segments: technology, end-user, and geography. Some examples of technological segments are LAMP, NASBA, PCR, and others. Pharmaceutical firms, academic and research institutes, and diagnostic labs are examples of end-users. The market is split geographically into Latin America, North America, Europe, Asia Pacific, the Middle East, and Africa.
Drivers of the Global Gene Amplification Technologies Market
The global market for gene amplification technologies is expanding due to the growing need for customized treatment and biotechnology breakthroughs. These technologies allow for the accurate and efficient examination of genetic material for research and diagnostic reasons.
Restraints in the Global Gene Amplification Technologies Market
Market expansion is impeded by ethical concerns over genetic manipulation, intricate regulatory frameworks, and high costs linked to gene amplification technologies. These factors may limit the broad use and growth of these technologies in the worldwide market.
Market Trends of the Global Gene Amplification Technologies Market
Key developments in the global gene amplification technologies market include the quick development of CRISPR-Cas9 technology, which allows for accurate and effective gene editing. Market growth is being propelled by expanding applications in biotechnology, agriculture, and medical research. Furthermore, the need for gene amplification techniques is fueled by the growth of customized medicine and synthetic biology. Efficiency gains come from automation and high-throughput capacities. Nonetheless, there are still issues with genetic modification in terms of ethics and regulations. All things considered, the market is driven by innovation, a wide range of applications, and rising funding for genetic research, with an emphasis on both therapeutic and non-therapeutic uses.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Gene Amplification Technologies Market by Technology
- Market Overview
- PCR
- NASBA
- LAMP
- and others
Global Gene Amplification Technologies Market by End user
- Market Overview
- Academic & research institutions
- diagnostic labs
- and pharmaceutical companies
Global Gene Amplification Technologies Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agilent Technologies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- QIAGEN (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Illumina (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Beckman Coulter (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fluidigm Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioMerieux (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GenMark Diagnostics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cepheid (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Luminex Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Enzo Biochem (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Takara Bio (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Promega Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton, Dickinson and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- DiaSorin S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eppendorf (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
